$Cassava Sciences(SAVA.US$ New SAVA Update April 25th , 2024 on Clinical Trials. Open-label Study of the Absorption, Metabolism, and Excretion" for SAVA's promising Phase 3 #Alzheimers drug candidate is now complete. - Thanks Archisaurus !
1
1
$Cassava Sciences(SAVA.US$ With another Insider Barry Richard acquiring even more new shares and no one selling. 1900 people are getting help treatments with no side effects, slowing decline and improving cognition. The rest of the world will truly benefit from this treatment very soon with phase 3 trials close to ending
2
$Cassava Sciences(SAVA.US$ Another Insider Acquiring More Shares. None of the Insiders sold any the stock shares. They continued to add more as we get closer to data Phase 3 trial Readout!!
1
2
$Cassava Sciences(SAVA.US$ New Promising Article: Cassava Sciences FLNA A will provide many benefits to Alzheimer's and possibly other diseases.
1
2
2
$Cassava Sciences(SAVA.US$ New Article on more benefits of FLNA . SAVA is definitely on the forefront of helping treat many diseases !
2
$Cassava Sciences(SAVA.US$ We all knew this was going to save lives and improve cognition and more families will benefit from SAVA treating Alzheimer’s soon. Very Good News!!!
2
$Cassava Sciences(SAVA.US$ As also shown in this article, People are losing their grandmothers, grandfathers, mothers and fathers to this disease. A treatment is absolutely needed and SAVA is showing promise . How dare you, shorts? How dare you try to stop phase 3 trials, call it a sugar pill/ no better than placebo and blast accusation statements on twitter to delay the trials and attempt to destroy the company’s reputation so you can short it and make money knowing that you or your family ...
2
$Cassava Sciences(SAVA.US$ Our Own Citizen's Petition should be to SEC & DOJ for short, false allegations and conflicts of interest from Bredt, Jordan Thomas, Adrian H, Jessee Brod, Bik since they have caused harm to the public by reporting false information against SAVA. They have harmed the public by delaying trials that were meant to assess a drug doing studies on volunteering patients with Alzheimers and they benefited by shorting the stock price and scaring the public. SAVA has now been in...
3